Molecular Mechanism for Low pH Triggered Misfolding of the Human Prion Protein
Authors:
- 22 February 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (11) , 3045-3054
Abstract
Conformational changes in the prion protein cause transmissible spongiform encephalopathies, also referred to as prion diseases. In its native state, the prion protein is innocuous (PrPC), but it can misfold into a neurotoxic and infectious isoform (PrPSc). The full-length cellular form of the prion protein consists of residues 23−230, with over half of the sequence belonging to the unstructured N-terminal domain and the remaining residues forming a small globular domain. During misfolding and aggregation, portions of both the structured and unstructured domains are incorporated into the aggregates. After limited proteolysis by proteinase K, the most abundant fragment from brain-derived prion fibrils is a 141-residue fragment composed of residues 90−230. Here we describe simulations of this fragment of the human prion protein at low pH, which triggers misfolding, and at neutral pH as a control. The simulations, in agreement with experiment, show that this biologically and pathologically relevant prion construct is stable and native-like at neutral pH. In contrast, at low pH the prion protein is destabilized via disruption of critical long-range salt bridges. In one of the low pH simulations this destabilization resulted in a conformational transition to a PrPSc-like isoform consistent with our previous simulations of a smaller construct.Keywords
This publication has 23 references indexed in Scilit:
- Putative aggregation initiation sites in prion proteinFEBS Letters, 2006
- Amyloid Formation by Recombinant Full-length Prion Proteins in Phospholipid Bicelle SolutionsJournal of Molecular Biology, 2006
- Prion disease geneticsEuropean Journal of Human Genetics, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Molecular Dynamics Simulation of Dimeric and Monomeric Forms of Human Prion Protein: Insight into Dynamics and PropertiesBiophysical Journal, 2003
- The Role of Helix 1 Aspartates and Salt Bridges in the Stability and Conversion of Prion ProteinJournal of Biological Chemistry, 2003
- Monoclonal antibodies inhibit prion replication and delay the development of prion diseaseNature, 2003
- A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic miceJournal of Molecular Biology, 2000
- Calibration and Testing of a Water Model for Simulation of the Molecular Dynamics of Proteins and Nucleic Acids in SolutionThe Journal of Physical Chemistry B, 1997
- Purification and properties of the cellular and scrapie hamster prion proteinsEuropean Journal of Biochemistry, 1988